Skip to main content

Table 4 Measles and Rubella seroprevalence rates demonstrated in different studies before and after MR campaign in Iran

From: Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran

Author/province Relation to 2003 MR campaign Years of study No of Subjects (Age-groups) Tested method Prevalence Rate
Measles Rubella
Emami-Naeini, Shiraz [33] Before 3-yr 2000 241 (19–25 yr) ELISA 40.7%  
Yekta, Uremia [34] Before (1- yr) 2002 835 (5–25 yr) ELISA 54.7%
Saffar, Sari [35] Before (1- yr) 2002 590(15–25 yr) ELISA 55.4%
Zamani, Tehran [36] Before (2- yr) 2001 1665 (6-11 yr) ELISA 72%
Salimi, Tabriz [37] Before (1- yr) 2002 225 (5–25 yr) HI test 91.6%
Pourabbas, Shiraz [24] After (1- yr) 2004–5 909(6-26 yr) ELISA 80.6–87.5% 91.0–99%
Yekta, Uremia [25] After (1- yr) 2004 624 (6-25 yr) ELISA 72.3%
Honarvar, Shiraz [26] After (7- yr) 2010–11 175 (16-24 yr) ELISA 81.7% 96%
Keshavarz, Tehran [27] After (10- yr) 2014 53 (19–26 yr) ELISA 79.2% 96.2%
Izadi, Bluchestan [28] After (12–13- yr) 2015 1056 (16–20 yr) ELISA 91.7% 87.4%
Karami, Hamadan [29] After (13- yr) 2016 272 (1–40 yr) ELISA 63.2%
  1. Yr Year, mo Months.
\